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Background
Medication-overuse headache (MOH) is a complication of
migraine that causes significant burden and cost. Recent
studies demonstrated metabolic and structural abnormal-
ities in MOH 1,2, including a grey matter increase in the
midbrain periaqueductal grey. We hypothesised that struc-
tural changes related to MOH should return to normal
after medication withdrawal in patients with significant
clinical improvement (responders). In contrast, no changes
were expected in patients without improvement (non-
responders).
Methods
Thirty-one MOH patients and 28 healthy controls were
investigated in a longitudinal voxel-based morphometry
study, comparing structural MRIs at 2 time points.
Results
In responders, grey matter in the midbrain decreased close
to normal values after withdrawal. In contrast, in non-
responders no grey matter decrease from scan 1 to scan 2
was observed. At baseline, non-responders had signifi-
cantly less grey matter in the right and left orbito-frontal
cortex, left insula, midbrain, and the thalami compared to
responders. In MOH patients grey matter in the right
gyrus rectus at base line correlated positively with treat-
ment response.
Conclusions
Increased grey matter in the midbrain, which is involved
in pain modulation, seems to decrease after successful
treatment. Poor response to treatment is associated with
decreased grey matter in the orbitofrontal cortex, con-
sistent with dysfunction of this region.
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